ASCRS 2024: CoFi integrates with CareCredit and marks participation milestone for ophthalmologists and optometrists


Sean Hanlon, CEO of CoFi, details the patient and provider benefits of recent CareCredit integration

At this year's ASCRS meeting in Boston, Massachusetts, Ophthalmology Times spoke with CoFi CEO Sean Hanlon. Here's what he had to say about CoFi's recent milestones, including the company's partnership with CareCredit.

Editor's note: The below transcript has been lightly edited for clarity.

Hi, I'm Sean Hanlon. I'm the CEO of CoFi. CoFi is a payment software company that enables patients to pay multiple providers involved in a surgery at one time. And we're really excited to be here at ASCRS and ASOA in Boston. We're based in Boston, so we're excited that the show is here, and it's great to see everybody.

A couple things that we're particularly excited about. Number one is we have announced the launch of our new integration with CareCredit. We're enabling multi-party or multi-provider patient financing, so patients can finance an entire procedure, including the surgeons' fees and any of their surgical partners' fees, like a surgery center, or a comanaging optometrist, and so on. The patient can have a single financing event. Those other partners just simply need to have a CoFi account in order to receive their funds. And so both CoFi and CareCredit are excited about this partnership, and excited to launch it; nationally, it's now commercially available.

The other thing we're excited about is CoFi, since we launched our company and launched our product, I should say, just under 3 years ago, we've now eclipsed 5,000 ophthalmologists and optometrists on our platform, a number that's growing by the hundreds every month. I think that's a testament to the fact that we've built, you know, a product that's solving some real needs in the market around payment compliance and payment convenience for patients, and convenience and sort of reduction of administrative burden for practices. So, always excited to come to ASCRS, and particularly excited this year. Hope to see folks while they're here or connect with you after the meeting. Thank you.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.